Britain to cover COVID-19 vaccine side-effects under damages scheme

▴ Britain to cover COVID-19 vaccine side-effects under damages scheme
Britain will pay individuals who suffer any severe side-effects from COVID-19 vaccines under an existing program.

Britain will pay individuals who suffer any severe side-effects from COVID-19 vaccines under an existing program, the government said on Thursday, ahead of a rollout of Pfizer and BioNTech’s vaccine in the country following emergency approval.

COVID-19 will be added as a "precautionary step" to the list of diseases covered for potential liabilities under the Vaccine Damage Payments Scheme (VDPS), the Department of Health and Social Care said. It added that vaccines would be deployed only after stringent checks. 

Compensation for any possible side-effects from a COVID-19 vaccine has been the subject of much debate in recent months, as drugmakers and governments around the world have worked in record time to develop and approve vaccines against the illness which has created havoc worldwide.

Britain's VDPS was set up in 1979 and covers victims of side-effects caused by common vaccines, such as those against measles, influenza, smallpox, and tetanus. In 2009 the vaccine against the H1N1 swine flu was also briefly added to the list.

Under the scheme, individuals are entitled to a lump sum capped at 120,000 pounds ($161,676) if they can prove to have been seriously disabled as a result of a vaccination.

The scheme is meant to dissuade people from seeking compensation through lengthy and costly court proceedings but has been criticized for the cap and its restrictive conditions.

“The current scheme is not really adequate for the current situation. If adverse events occur, the route to compensation is too complicated. It would be much better if the government set up a bespoke scheme for COVID-19,” said Duncan Fairgrieve, of the British Institute of International and Comparative Law.

Britain said it would continue to monitor the safety of Pfizer and BioNTech’s vaccine after the country on Wednesday became the first in the Western world to approve a COVID-19 vaccine.

The emergency use authorization does not include liabilities, however, unlike a conditional approval granted by the European Union.

Tags : #Britain #Pfizer #BioNTech #Covid19 #Covid19Vaccine #VaccineSideEffects #BritainGovernment #Compensation #VDPS #WesternWorld #OtherDiseases #CovidUpdates

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Children in Cities Exposed to Elevated Lead Levels: Study Reveals Urgent Health ConcernApril 20, 2024
Biocon Ventures into Weight-Loss Drug Market with Semaglutide DevelopmentApril 20, 2024
Innovative AI Assistance Empowers Moscow Doctors to Detect Cervical Spine Issues through MRI ScansApril 20, 2024
Air India Express ties up with AISATS for AeroWash Automated Aircraft Exterior Cleanings April 19, 2024
IndoSup raises strategic funding led by CCI group promoters Naresh Sharma and Satish Sharma; investors include Yatra.com’s Rohan Mittal April 19, 2024
10 compelling reasons why choosing right media platform Is important in healthcareApril 19, 2024
Protecting Public Health: Proposed Guidelines for Pharmaceutical Product DistributionApril 19, 2024
What is Haemophilia: A Genetic Bleeding Disorder that has Affected 1,36,000 IndiansApril 19, 2024
Climate Change and Stroke Risk: Exploring the Impact of Temperature Fluctuations on Your Body April 19, 2024
The Extension and Benefits of ABHA Linking with CGHS Beneficiary ID: What You Need to KnowApril 19, 2024
Mental Health Issues Impact Studies in 3 out 4 Female Students: PeakMind StudyApril 18, 2024
Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) signs agreement for placement of equipment with Thermo Fisher Scientific to help advance innovation in India April 18, 2024
MiracleMe Introduces Revolutionary Orally Dissolving Plant-Based Nutrition ProductsApril 18, 2024
South Indian Bank signs MOU with Ashok Leyland Limited for Dealer FinancingApril 18, 2024
Serum Institute of India Partners with Oxford University to Develop Meningitis-B VaccineApril 18, 2024
Ethical Concerns Arise: Nestlé Accused of Adding Sugar and Honey to Infant Formula and Breakfast Cereals in Low-Income CountriesApril 18, 2024
Empowering India's Youth: IG Drones & AASSC Launch Drone Skill Program, to Upskill 10M YouthApril 17, 2024
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment TechnologyApril 17, 2024
Top 5 online learning platform for learnersApril 17, 2024
Broad-Spectrum RNA Vaccine Breakthrough for Enhanced Virus ProtectionApril 17, 2024